oxybutynin has been researched along with Auricular Fibrillation in 7 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The incidence of adverse events did not differ between the groups." | 6.90 | Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study). ( Akita, Y; Ikeda, T; Yamashita, T, 2019) |
| "We examined the efficacy of TDPB for paroxysmal atrial fibrillation (PAF) after open heart surgery." | 5.46 | [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery]. ( Enomoto, S; Hamuro, M; Kawatou, M; Yamada, T; Yamamoto, K, 2017) |
| "The bisoprolol patch was introduced 88 h after the start of landiolol administration, when the rate was approximately 3 μg/kg/min." | 5.43 | Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia. ( Doi, K; Hiruma, T; Inokuchi, R; Nakajima, S; Nakamura, K; Tokunaga, K, 2016) |
| "The transdermal formulation of bisoprolol may be useful for the early introduction of β-blockers in patients admitted with cardiac symptoms associated with myocardial ischemia or heart failure." | 4.02 | An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms. ( Horiuchi, N; Kobayashi, T; Kobayashi, Y; Nakamura, S; Nakanishi, H; Naruhashi, K; Nozaki, A; Okugawa, H, 2021) |
| " The incidence of adverse events did not differ between the groups." | 2.90 | Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study). ( Akita, Y; Ikeda, T; Yamashita, T, 2019) |
| "We examined the efficacy of TDPB for paroxysmal atrial fibrillation (PAF) after open heart surgery." | 1.46 | [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery]. ( Enomoto, S; Hamuro, M; Kawatou, M; Yamada, T; Yamamoto, K, 2017) |
| "The bisoprolol patch was introduced 88 h after the start of landiolol administration, when the rate was approximately 3 μg/kg/min." | 1.43 | Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia. ( Doi, K; Hiruma, T; Inokuchi, R; Nakajima, S; Nakamura, K; Tokunaga, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Nozaki, A | 1 |
| Kobayashi, T | 1 |
| Naruhashi, K | 1 |
| Okugawa, H | 1 |
| Horiuchi, N | 1 |
| Nakanishi, H | 1 |
| Kobayashi, Y | 1 |
| Nakamura, S | 1 |
| Iwano, T | 1 |
| Toda, H | 1 |
| Nakamura, K | 2 |
| Shimizu, K | 1 |
| Ejiri, K | 1 |
| Naito, Y | 1 |
| Mori, H | 1 |
| Masuda, T | 1 |
| Miyoshi, T | 1 |
| Yoshida, M | 1 |
| Hikasa, Y | 1 |
| Morimatsu, H | 1 |
| Ito, H | 1 |
| Yamamoto, K | 1 |
| Yamada, T | 1 |
| Hamuro, M | 1 |
| Kawatou, M | 1 |
| Enomoto, S | 1 |
| Yamashita, T | 1 |
| Ikeda, T | 1 |
| Akita, Y | 1 |
| Okamura, H | 1 |
| Arakawa, M | 1 |
| Miyagawa, A | 1 |
| Adachi, H | 1 |
| Lee, J | 1 |
| Burke, DT | 1 |
| Inokuchi, R | 1 |
| Hiruma, T | 1 |
| Tokunaga, K | 1 |
| Doi, K | 1 |
| Nakajima, S | 1 |
2 trials available for oxybutynin and Auricular Fibrillation
| Article | Year |
|---|---|
Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
Topics: Aged; Atrial Fibrillation; Bisoprolol; Humans; Postoperative Complications; Risk Factors; Stroke; Tr | 2021 |
Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Atrial Fibrillatio | 2019 |
5 other studies available for oxybutynin and Auricular Fibrillation
| Article | Year |
|---|---|
An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
Topics: Acute Coronary Syndrome; Acute Disease; Administration, Cutaneous; Adrenergic beta-1 Receptor Antago | 2021 |
[Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atrial Fibrillation; Bisoprolol; Cardiac Surgical | 2017 |
Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Cardiac Surgical Proce | 2019 |
Lower gastrointestinal bleeding associated with diclofenac topical patch in a patient with colonic mass and on antiplatelet therapy for atrial fibrillation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Clopidogrel; Colonic Neoplasms; | 2014 |
Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; B | 2016 |